TrialTranslational psychiatry2022

Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study.

Vibeke Høyrup Dam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.